Epizyme, Inc.

D. E. Shaw & Co., Inc.

Report date

6/30/2022

Quarter

2022 Q2

Filed

8/15/2022

Shares

1,728,102

Value ($000)

2,540

Weight

0.0%

2019 Q4 - 2022 Q2 (8 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2022 Q2	8/15/2022	2,540	0.0%	1,728,102	6/30/2022
2022 Q1	5/16/2022	2,669	0.0%	2,320,698	3/31/2022
2021 Q4	2/14/2022	649	0.0%	259,522	12/31/2021
2021 Q1	5/17/2021	384	0.0%	44,130	3/31/2021
2020 Q4	2/16/2021	1,040	0.0%	95,738	12/31/2020
2020 Q3	11/16/2020	478	0.0%	40,106	9/30/2020
2020 Q1	5/15/2020	173	0.0%	11,124	3/31/2020
2019 Q4	2/14/2020	4,635	0.0%	188,424	12/31/2019